Posted on October 29th, 2008 by Health News
(Porter Novelli) Shire plc, the global specialty biopharmaceutical company, announced results from a 13-hour classroom study in children aged 6 to 12 years with attention deficit hyperactivity disorder, in which researchers found that VYVANSE CII controlled ADHD symptoms from the first time measured (1.5 hours) through the last time point assessed (13 hours) post-dose. The study findings were at a national psychiatric meeting in Chicago.
Read more
Filed under: General Health News
Tags: ADHD, General Health News
Related posts
- Wide Global Variation in ADHD Diagnosis and Treatment (0)
The prevalence of ADHD differs across nations, but most of the differences are due to disparate diagnostic practices. Medscape Medical News
Read more
[tags] General Health News [/tags]
- Transcendental meditation reduces ADHD symptoms among students: New study (0)
(Maharishi University of Management) The transcendental meditation technique may be an effective and safe non-pharmaceutical aid for treating ADHD, according to a promising new study published this month in the peer-reviewed online journal Current Issues in Education.The pilot study followed a group of middle school students with ADHD who were meditating twice a day in [...]
- Study: Childhood constipation just as serious as asthma (0)
(Nationwide Children's Hospital) Family life gets crazy around the holidays, and kids can get out of their bathroom routine. A new study finds childhood constipation is much more than an inconvenience - it's a common, sometimes serious medical problem that costs nearly $4 billion each year to treat. That's equal to major chronic [...]
- Shire to enter European ADHD market with acquisition of EQUASYM IR and XL (0)
Shire plc has announced that it has signed an agreement with UCB to acquire the worldwide rights to EQUASYM IR and XL (methylphenidate hydrochloride) (excluding the USA, Canada and Barbados) used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Read more
[tags] General Health News [/tags]
- Secondhand Smoke Boosts Neurobehavioral Problems in Kids (0)
Children exposed to tobacco smoke at home have an increased risk of having common neurobehavioral disorders, such as learning disabilities, conduct problems, and ADHD. Medscape Medical News
Read more
[tags] General Health News [/tags]
Leave a Reply